{"id":70741,"title":"Share Talk Bulletin Board Heroes, Pharma Special, Tuesday 5th May 2020","publisher":"Share Talk","author":"sharetalk","published":"2020-05-05T15:48:37+00:00","modified":"2020-05-05T20:05:57+00:00","canonical_url":"https://www.share-talk.com/share-talk-bulletin-board-heroes-pharma-special-tuesday-5th-may-2020/","markdown_url":"https://www.share-talk.com/share-talk-bulletin-board-heroes-pharma-special-tuesday-5th-may-2020.md","json_url":"https://www.share-talk.com/share-talk-bulletin-board-heroes-pharma-special-tuesday-5th-may-2020.json","category":"Bulletin Board Heroes","categories":["Bulletin Board Heroes","Zak Mir"],"tags":["4d Pharma","Avacta Group","AVCT","DDDD","GDR","Genedrive","HEMO","Hemogenyx Pharmaceuticals","Motif Bio","MTFB","NCYT","Novacyt SA","ODX","Omega Diagnostics Group","Open Orphan","ORPH","SNG","Synairgen","TILS","Tiziana Life Sciences","VAL","ValiRx"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1","format":"news","language":"en-GB","content":"Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Here is our small-cap pharmaceutical special.\n\n**Avacta Group (AVCT)\n\n4d Pharma (DDDD)\n\nGenedrive (GDR)\n\nHemogenyx Pharmaceuticals (HEMO)\n\nMotif Bio (MTFB)\n\nNovacyt SA (NCYT)\n\nOmega Diagnostics Group (ODX)\n\nOpen Orphan (ORPH)\n\nSynairgen (SNG)\n\nTiziana Life Sciences (TILS)\n\nValiRx (VAL)**\n\n[@ZaksTradersCafe](https://twitter.com/ZaksTradersCafe) deductive reasoning as to what may happen next in terms of the chart’s regarding the companies listed in this video.\n\n \n\n[Zakmir.com](https://zakmir.com/) is a purely journalistic website – Zak Mir is a member of the National Union of Journalists. There is no intention here of providing financial advice. It is recommended you seek an independent professional opinion before deciding whether or not to take any action with regard to anything written here.\n\n![](https://www.share-talk.com/wp-content/uploads/2020/01/Image-2019-08-20-at-11.45.18-AM-234x300.png)"}